https://orcid.org/0000-0001-8926-0113
Citations (106)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Jason E Hawkes, Dale V Reisner & Tina Bhutani. (2023) Exploring the Quality-of-Life Impact, Disease Burden, and Management Challenges of GPP: The Provider and Patient Perspective [Podcast]. Clinical, Cosmetic and Investigational Dermatology 16, pages 3333-3339.
Read now
Read now
Tina Bhutani & Jason E Hawkes. (2023) Exploring the Clinical Features, Immunopathogenesis and Approach to Diagnosis for Generalized Pustular Psoriasis [Podcast]. Clinical, Cosmetic and Investigational Dermatology 16, pages 1553-1558.
Read now
Read now
Xujun Lu & Wenge Wang. (2023) Treatment of Erythrodermic Psoriasis in Children with Secukinumab: A Case Report. Clinical, Cosmetic and Investigational Dermatology 16, pages 1977-1981.
Read now
Read now
Luca Potestio, Elisa Camela, Sara Cacciapuoti, Fabrizio Martora, Luigi Guerriero, Luigi Fornaro, Angelo Ruggiero & Matteo Megna. (2023) Efficacy and safety of spesolimab for the management of generalized pustular psoriasis: a drug safety evaluation. Expert Opinion on Drug Safety 22:11, pages 1003-1010.
Read now
Read now
Marc Ferrante, Peter M Irving, Christian P Selinger, Geert D’Haens, Tanja Kuehbacher, Ursula Seidler, Savion Gropper, Thomas Haeufel, Sebastiano Forgia, Silvio Danese, Jochen Klaus & Brian G. Feagan$suffix/text()$suffix/text(). (2023) Safety and tolerability of spesolimab in patients with ulcerative colitis. Expert Opinion on Drug Safety 22:2, pages 141-152.
Read now
Read now
Jiajing Lu & Yuling Shi. (2022) A review of disease burden and clinical management for generalized pustular psoriasis in China. Expert Review of Clinical Immunology 18:10, pages 1023-1032.
Read now
Read now
Hervé Bachelez, Jonathan Barker, A. David Burden, Alexander A. Navarini & James G. Krueger. (2022) Generalized pustular psoriasis is a disease distinct from psoriasis vulgaris: evidence and expert opinion. Expert Review of Clinical Immunology 18:10, pages 1033-1047.
Read now
Read now
Cláudia Oliveira Maçães, Ana Maria Lé & Tiago Torres. (2022) Generalized pustular psoriasis: the new era of treatment with IL-36 receptor inhibitors. Journal of Dermatological Treatment 33:7, pages 2911-2918.
Read now
Read now
Mayumi Komine & Akimichi Morita. (2021) Generalized pustular psoriasis: current management status and unmet medical needs in Japan. Expert Review of Clinical Immunology 17:9, pages 1015-1027.
Read now
Read now
Maya L. Hanna, David Singer & Wendell C. Valdecantos. (2021) Economic burden of generalized pustular psoriasis and palmoplantar pustulosis in the United States. Current Medical Research and Opinion 37:5, pages 735-742.
Read now
Read now
Jeffrey J. Crowley, David M. Pariser & Paul S. Yamauchi. (2021) A brief guide to pustular psoriasis for primary care providers. Postgraduate Medicine 133:3, pages 330-344.
Read now
Read now
Helena Iznardo & Lluís Puig. (2021) The interleukin-1 family cytokines in psoriasis: pathogenetic role and therapeutic perspectives. Expert Review of Clinical Immunology 17:2, pages 187-199.
Read now
Read now
Saifuddin Kharawala, Amanda K. Golembesky, Rhonda L. Bohn & Dirk Esser. (2020) The clinical, humanistic, and economic burden of generalized pustular psoriasis: a structured review. Expert Review of Clinical Immunology 16:3, pages 239-252.
Read now
Read now
Articles from other publishers (93)
Anna Balato, Francesca Ambrogio, Martina Burlando, Carlo Giovanni Carrera, Andrea Chiricozzi, Maria Esposito, Stefano Piaserico, Miriam Teoli & Paolo Gisondi. (2023) Commentary: Unmet Needs in Generalized Pustular Psoriasis in Clinical Practice. Dermatology and Therapy.
Crossref
Crossref
Koremasa Hayama, Ryoko Iwasaki, Yahui Tian & Hideki Fujita. (2023) Factors associated with generalized pustular psoriasis progression among patients with psoriasis vulgaris in Japan: Results from a claims database study. The Journal of Dermatology 50:12, pages 1531-1538.
Crossref
Crossref
Tsen-Fang Tsai, Min Zheng, Yangfeng Ding, Zhiqi Song, Quanzhong Liu, Ying Chen, Hanzhao Hu & Jinhua Xu. (2023) Efficacy and Safety of Spesolimab in Patients with Generalized Pustular Psoriasis: A Subgroup Analysis of Chinese Patients in the Effisayil 1 Trial. Dermatology and Therapy 13:12, pages 3097-3110.
Crossref
Crossref
Jason E. Hawkes, Sudha Visvanathan & James G. Krueger. (2023) The role of the interleukin-36 axis in generalized pustular psoriasis: a review of the mechanism of action of spesolimab. Frontiers in Immunology 14.
Crossref
Crossref
Akimichi Morita, Bruce Strober, A David Burden, Siew Eng Choon, Milan J Anadkat, Slaheddine Marrakchi, Tsen-Fang Tsai, Kenneth B Gordon, Diamant Thaçi, Min Zheng, Na Hu, Thomas Haeufel, Christian Thoma & Mark G Lebwohl. (2023) Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial. The Lancet 402:10412, pages 1541-1551.
Crossref
Crossref
Thomas M. Zimmermann, Patrick Hofmann & Gretchen R. Chiu. (2023) A narrative review of the socioeconomic burden associated with generalised pustular psoriasis. Experimental Dermatology 32:8, pages 1219-1226.
Crossref
Crossref
Siew Eng Choon, Boni E. Elewski, Hideki Fujita, Songmei Geng, Peter van de Kerkhof, Sicily Mburu, Lluís Puig, Ricardo Romiti & Marina Venturini. (2023)
Diversity in the clinical presentation of generalized pustular psoriasis (
GPP
): A series of case vignettes from around the world
. Experimental Dermatology 32:8, pages 1284-1295.
Crossref
Crossref
Siew Eng Choon, Peter Seah Keng Tok, Kit Wan Wong, Yee Ting Lim, Nalini M. Nanu, Jonathan N. Barker & Francesca Capon. (2023)
Clinical profile of patients with acute generalized pustular psoriasis with and without
IL36RN
mutations in multi‐ethnic Johor Bahru, Malaysia
. Experimental Dermatology 32:8, pages 1263-1271.
Crossref
Crossref
Rhea Malik, Jeffrey Chen, Charles Lau, Aaron Sandoval & Vinod E. Nambudiri. (2023) Generalized pustular psoriasis: Quality and readability of online health information. Experimental Dermatology 32:8, pages 1317-1321.
Crossref
Crossref
Xin Yun Teoh, Robinson Suganthy, Sook Yee Michelle Voo & Min Moon Tang. (2023) Pustular psoriasis in Malaysia: A review of the Malaysian Psoriasis Registry 2007–2018. Experimental Dermatology 32:8, pages 1253-1262.
Crossref
Crossref
Nilesh Kodali, Isabella Blanchard, Sruthi Kunamneni & Mark G. Lebwohl. (2023) Current management of generalized pustular psoriasis. Experimental Dermatology 32:8, pages 1204-1218.
Crossref
Crossref
Qilin Zhang, Peidian Shi, Zhenzhen Wang, Lele Sun, Wenchao Li, Qing Zhao, Tingting Liu, Qing Pan, Yuanhang Sun, Fengming Jia, Wenjie Chen, Xi’an Fu, Gongqi Yu, Fangfang Bao, Zihao Mi, Chuan Wang, Yonghu Sun, Bingqing Li, Jianjun Liu, Hong Liu, Heng Gu & Furen Zhang. (2023) Identification of the BTN3A3 Gene as a Molecule Implicated in Generalized Pustular Psoriasis in a Chinese Population. Journal of Investigative Dermatology 143:8, pages 1439-1448.e21.
Crossref
Crossref
Abrahim Abduelmula, Brian D. Rankin, Siddhartha Sood, Jorge R. Georgakopoulos, Asfandyar Mufti, Ronald Vender, Jensen Yeung & Vimal H. Prajapati. (2023) Management of adult generalized pustular psoriasis using biologics: A systematic review. Journal of the American Academy of Dermatology 89:2, pages 417-419.
Crossref
Crossref
Richard B Warren, Adam Reich, Andrzej Kaszuba, Waldemar Placek, Christopher E M Griffiths, Jihao Zhou, Bruce Randazzo, Paul Lizzul & Johann E Gudjonsson. (2023) Imsidolimab, an anti-interleukin-36 receptor monoclonal antibody, for the treatment of generalized pustular psoriasis: results from the phase II GALLOP trial. British Journal of Dermatology 189:2, pages 161-169.
Crossref
Crossref
Kanika Kamal, Grant J. Riew, Baraa Hijaz, Simon M. Helfgott, Alvaro C. Laga & Vinod E. Nambudiri. (2023)
Generalized pustular psoriasis‐like widespread eruption following
COVID
‐19 infection in a patient with spondyloarthropathy on adalimumab
. Experimental Dermatology.
Crossref
Crossref
Joseph Masison, Jonas A. Adalsteinsson & Mary Wu Chang. (2023) Distinguishing annular pustular psoriasis from subcorneal pustular dermatosis—A diagnostic dilemma in a 10‐year‐old boy. Pediatric Dermatology 40:4, pages 698-701.
Crossref
Crossref
Hai-Meng Wang, Jia-Ming Xu & Hong-Zhong Jin. (2023) Characteristics and Burdens of Disease in Patients from Beijing with Generalized Pustular Psoriasis and Palmoplantar Pustulosis: Multicenter Retrospective Cohort Study Using a Regional Database. American Journal of Clinical Dermatology.
Crossref
Crossref
Aurora Fernández‐Galván, Esteban Daudén, Beatriz Butron‐Bris, Mireia Seguí‐Olmedilla, Ana Miguélez, Javier Fraga, Pedro Rodríguez Jiménez & Mar Llamas‐Velasco. (2023) First experiences in real clinical practice treating a patient with generalised pustular psoriasis with Spesolimab. JEADV Clinical Practice 2:2, pages 369-372.
Crossref
Crossref
Divya Thirumal, Rakesh K. Sindhu, Shuchi Goyal, Aayush Sehgal, Ashok Kumar, Marianesan Arockia Babu & Pradeep Kumar. (2023) Pathology and Treatment of Psoriasis Using Nanoformulations. Biomedicines 11:6, pages 1589.
Crossref
Crossref
Biju Vasudevan, Pankaj Das & Siddharth Bhatt. (2023) Pustular psoriasis: A distinct aetiopathogenic and clinical entity. Indian Journal of Dermatology, Venereology and Leprology 0, pages 1-11.
Crossref
Crossref
Alexander C. Martins, Fernando Albericio & Beatriz G. de la Torre. (2023) FDA Approvals of Biologics in 2022. Biomedicines 11:5, pages 1434.
Crossref
Crossref
Siew Eng Choon, Alison K Wright, Christopher E M Griffiths, Kit Wan Wong, Kwee Eng Tey, Yee Ting Lim, Keow Yin Chua & Darren M Ashcroft. (2023) Incidence and prevalence of generalized pustular psoriasis in multiethnic Johor Bahru, Malaysia: a population-based cohort study using routinely captured electronic health records in the Teleprimary Care (TPC®) clinical information system from 2010 to 2020. British Journal of Dermatology.
Crossref
Crossref
Jiayan Li, Xue Gao, Lili Ma & Yimiao Fang. (2023) Secukinumab for the treatment of generalized pustular psoriasis: A case report. Medicine 102:18, pages e33693.
Crossref
Crossref
Valentina Laura Müller & Alexander Kreuter. (2023) Remission einer therapierefraktären generalisierten pustulösen Psoriasis unter dem Interleukin-36-Rezeptor-Inhibitor SpesolimabRemission of recalcitrant generalized pustular psoriasis under interleukin-36 receptor inhibitor spesolimab. Die Dermatologie 74:5, pages 356-359.
Crossref
Crossref
Lluís Puig, Siew Eng Choon, Alice B. Gottlieb, Slaheddine Marrakchi, Jörg C. Prinz, Ricardo Romiti, Yayoi Tada, Dorothea von Bredow & Melinda Gooderham. (2023) Generalized pustular psoriasis: A global Delphi consensus on clinical course, diagnosis, treatment goals and disease management. Journal of the European Academy of Dermatology and Venereology 37:4, pages 737-752.
Crossref
Crossref
Alexander A. Navarini, Jörg C. Prinz, Akimichi Morita, Tsen‐Fang Tsai, Manuelle‐Anne Viguier, Ling Li, Christian Thoma, Mogana Sivalingam & Mark G. Lebwohl. (2023) Spesolimab improves patient‐reported outcomes in patients with generalized pustular psoriasis: Results from the Effisayil 1 study. Journal of the European Academy of Dermatology and Venereology 37:4, pages 730-736.
Crossref
Crossref
A. David Burden, Robert Bissonnette, Mark G. Lebwohl, Tristan Gloede, Milena Anatchkova, Ismail Budhiarso, Na Hu, Christian Thoma, Anne M. Skalicky & Hervé Bachelez. (2023)
Psychometric validation of the generalized pustular psoriasis physician global assessment (
GPPGA
) and generalized pustular psoriasis area and severity index (
GPPASI
)
. Journal of the European Academy of Dermatology and Venereology.
Crossref
Crossref
Raquel Rivera-Díaz, Esteban Daudén, José Manuel Carrascosa, Pablo de la Cueva & Luis Puig. (2023) Generalized Pustular Psoriasis: A Review on Clinical Characteristics, Diagnosis, and Treatment. Dermatology and Therapy 13:3, pages 673-688.
Crossref
Crossref
Jörg C. Prinz, Siew Eng Choon, Christopher E. M. Griffiths, Joseph F. Merola, Akimichi Morita, Darren M. Ashcroft & Manuelle Viguier. (2022) Prevalence, comorbidities and mortality of generalized pustular psoriasis: A literature review. Journal of the European Academy of Dermatology and Venereology 37:2, pages 256-273.
Crossref
Crossref
Claire E. Kovalchin, Jessica Kaffenberger, John Trinidad, Ty W. Gilkey, Abena Minta, Johann Gudjonsson & Benjamin H. Kaffenberger. (2023) Characterizing risk factors for hospitalization for psoriasis patients. Archives of Dermatological Research 315:6, pages 1541-1546.
Crossref
Crossref
Koji Kamiya & Mamitaro Ohtsuki. (2022) Epidemiological survey of patients with pustular psoriasis in the Japanese Society for Psoriasis Research from 2017 to 2020. The Journal of Dermatology 50:1, pages 3-11.
Crossref
Crossref
Akimichi Morita, Siew Eng Choon, Hervé Bachelez, Milan J. Anadkat, Slaheddine Marrakchi, Min Zheng, Tsen-Fang Tsai, Hamida Turki, Harry Hua, Sushmita Rajeswari, Christian Thoma & A. David Burden. (2022) Design of Effisayil™ 2: A Randomized, Double-Blind, Placebo-Controlled Study of Spesolimab in Preventing Flares in Patients with Generalized Pustular Psoriasis. Dermatology and Therapy 13:1, pages 347-359.
Crossref
Crossref
Anastasia Drakos & Ronald Vender. (2022) A Review of the Clinical Trial Landscape in Psoriasis: An Update for Clinicians. Dermatology and Therapy 12:12, pages 2715-2730.
Crossref
Crossref
Shuai Shao & Gang Wang. (2022) Commentary on a Clinical Trial of Spesolimab, a Humanized Anti-interleukin-36 Receptor Monoclonal Antibody, in Generalized Pustular Psoriasis. Dermatology and Therapy 12:12, pages 2627-2635.
Crossref
Crossref
N. S. Rudneva, E. V. Natarova & L. S. Kruglova. (2022) Pustular psoriasis treated with IL-17a antibody secukinumab. Medical alphabet 1:27, pages 30-36.
Crossref
Crossref
Hannah A. Blair. (2022) Spesolimab: First Approval. Drugs 82:17, pages 1681-1686.
Crossref
Crossref
Carla L. Zema, Wendell C. Valdecantos, Jonathan Weiss, Blake Krebs & Alan M. Menter. (2022) Understanding Flares in Patients With Generalized Pustular Psoriasis Documented in US Electronic Health Records. JAMA Dermatology 158:10, pages 1142.
Crossref
Crossref
Jan Koren, Sicily Mburu, David Trigos, Giovanni Damiani & Luigi Naldi. (2022) Generalized pustular psoriasis: the case for rare disease and orphan designation. British Journal of Dermatology 187:3, pages 411-413.
Crossref
Crossref
Mariko Seishima, Kento Fujii & Yoko Mizutani. (2022) Generalized Pustular Psoriasis in Pregnancy: Current and Future Treatments. American Journal of Clinical Dermatology 23:5, pages 661-671.
Crossref
Crossref
Jyoti Sharma & Ripu Daman. (2022) Molecular Analysis, Pathophysiology, and Drug Delivery Mechanism with Reference to Psoriasis: A Review. Oriental Journal Of Chemistry 38:4, pages 940-947.
Crossref
Crossref
Helena Iznardo & Luís Puig. (2022) IL-1 Family Cytokines in Inflammatory Dermatoses: Pathogenetic Role and Potential Therapeutic Implications. International Journal of Molecular Sciences 23:16, pages 9479.
Crossref
Crossref
A. Kara Polat, E. Alpsoy, G. Kalkan, S. Aytekin, D. Uçmak, R. Yasak Güner, Z. Topkarcı, O. Yılmaz, S. Emre, M. Borlu, Z. Türkoğlu, T. Özkök Akbulut, G. Özaydın Yavuz, H. Kaya Erdoğan, E. Adışen, A. Satılmış Kaya, İ. Oğuz Topal, S. Yazıcı, E. Yılmaz, A.E. Koku Aksu, S.P. Kartal, B.N. Deveci, E. Öksüm Solak, A.S. Karadağ, S. Sarıkaya Solak, İ. Kıvanç Altunay, A. Türel Ermertcan, B. Özkesici Kurt, N. Gelincik Kaçar & A. Ataseven. (2022) Sociodemographic, clinical, laboratory, treatment and prognostic characteristics of 156 generalized pustular psoriasis patients in Turkey: a multicentre case series. Journal of the European Academy of Dermatology and Venereology 36:8, pages 1256-1265.
Crossref
Crossref
Mariem Ennouri, Emna Bahloul, Khadija Sellami, Slaheddine Marrakchi, Faiza Fakhfakh, Hamida Turki & Noura Bougacha‐Elleuch. (2022) Pustular psoriasis of pregnancy: Clinical and genetic characteristics in a series of eight patients and review of the literature. Dermatologic Therapy 35:8.
Crossref
Crossref
Renata Ferreira Magalhães, Gabriela Della Ripa Rodrigues Assis, Ana Cecília Versiani Duarte Espindola, Maria Luiza Camprigher Witzler, Andreea Anton, Faris Kubba, Maria Letícia Cintra & Fernanda Teixeira. (2022) Immunophenotypic profile of macrophages in generalized pustular psoriasis and deficiency of the interleukin-36 receptor antagonist. Clinical and Experimental Dermatology 47:8, pages 1578-1581.
Crossref
Crossref
Kacey L. Sachen, Carrie N. Arnold Greving & Jennifer E. Towne. (2022) Role of IL-36 cytokines in psoriasis and other inflammatory skin conditions. Cytokine 156, pages 155897.
Crossref
Crossref
Ludovic Amruthalingam, Oliver Buerzle, Philippe Gottfrois, Alvaro Gonzalez Jimenez, Anastasia Roth, Thomas Koller, Marc Pouly & Alexander A. Navarini. (2022) Quantification of Efflorescences in Pustular Psoriasis Using Deep Learning. Healthcare Informatics Research 28:3, pages 222-230.
Crossref
Crossref
Jungyoon Ohn, Young‐Geun Choi, Jieun Yun & Seong Jin Jo. (2022) Identifying patients with deteriorating generalized pustular psoriasis: Development of a prediction model. The Journal of Dermatology 49:7, pages 675-681.
Crossref
Crossref
Kristian ReichMatthias AugustinSascha Gerdes, Kamran Ghoreschi, Georgios Kokolakis, Rotraut Mößner, Ulrich Mrowietz, Alexander A. Navarini, Andreas Pinter, Knut Schäkel, Petra Staubach, Michael Sticherling, Diamant Thaçi & Dagmar Wilsmann‐Theis. (2022) Generalisierte pustulöse Psoriasis: Überblick zum Status quo und Ergebnisse einer Diskussionsrunde. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 20:6, pages 753-772.
Crossref
Crossref
Kristian Reich, Matthias Augustin, Sascha Gerdes, Kamran Ghoreschi, Georgios Kokolakis, Rotraut Mößner, Ulrich Mrowietz, Alexander A. Navarini, Andreas Pinter, Knut Schäkel, Petra Staubach, Michael Sticherling, Diamant Thaçi & Dagmar Wilsmann‐Theis. (2022) Generalized pustular psoriasis: overview of the status quo and results of a panel discussion. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 20:6, pages 753-771.
Crossref
Crossref
Siew Eng Choon & Hervé Bachelez. (2022) Time to accurately determine the burden of generalized pustular psoriasis at the population level. British Journal of Dermatology 186:6, pages 919-920.
Crossref
Crossref
Hideaki Miyachi, Takaaki Konishi, Ryosuke Kumazawa, Hiroki Matsui, Sayuri Shimizu, Kiyohide Fushimi, Hiroyuki Matsue & Hideo Yasunaga. (2022) Treatments and outcomes of generalized pustular psoriasis: A cohort of 1516 patients in a nationwide inpatient database in Japan. Journal of the American Academy of Dermatology 86:6, pages 1266-1274.
Crossref
Crossref
Yukari Okubo, Yoshinori Umezawa, Shinya Sakurai, Naoki Hoshii & Hidemi Nakagawa. (2022) Efficacy and Safety of Certolizumab Pegol in Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis: 52-Week Results. Dermatology and Therapy 12:6, pages 1397-1415.
Crossref
Crossref
M Lebwohl, R A. Medeiros, R H. Mackey, L R. Harrold, W C. Valdecantos, M Flack, A K. Golembesky, N Kotowsky & B Strober. (2022) The Disease Burden of Generalized Pustular Psoriasis: Real-World Evidence From CorEvitas’ Psoriasis Registry. Journal of Psoriasis and Psoriatic Arthritis 7:2, pages 71-78.
Crossref
Crossref
Patrick Baum, Sudha Visvanathan, Sandra Garcet, Janine Roy, Ramona Schmid, Sebastian Bossert, Benjamin Lang, Hervé Bachelez, Robert Bissonnette, Christian Thoma & James G. Krueger. (2022) Pustular psoriasis: Molecular pathways and effects of spesolimab in generalized pustular psoriasis. Journal of Allergy and Clinical Immunology 149:4, pages 1402-1412.
Crossref
Crossref
Steffen Schrenker & Luise Erpenbeck. (2022) Neutrophile Dermatosen. hautnah dermatologie 38:2, pages 44-50.
Crossref
Crossref
Kazumitsu Sugiura. (2022) Role of Interleukin 36 in Generalised Pustular Psoriasis and Beyond. Dermatology and Therapy 12:2, pages 315-328.
Crossref
Crossref
Bruce Strober, Joyce Leman, Maja Mockenhaupt, Juliana Nakano de Melo, Ahmed Nassar, Vimal H. Prajapati, Paolo Romanelli, Julien Seneschal, Athanasios Tsianakas, Lee Yoong Wei, Masahito Yasuda, Ning Yu, Ana C. Hernandez Daly & Yukari Okubo. (2021) Unmet Educational Needs and Clinical Practice Gaps in the Management of Generalized Pustular Psoriasis: Global Perspectives from the Front Line. Dermatology and Therapy 12:2, pages 381-393.
Crossref
Crossref
Syeda Fatima Aijaz, Saad Jawaid Khan, Fahad Azim, Choudhary Sobhan Shakeel & Umer Hassan. (2022) Deep Learning Application for Effective Classification of Different Types of Psoriasis. Journal of Healthcare Engineering 2022, pages 1-12.
Crossref
Crossref
Marie-Anne Morren, Eric Legius, Fabienne Giuliano, Smail Hadj-Rabia, Daniel Hohl & Christine Bodemer. (2022) Challenges in Treating Genodermatoses: New Therapies at the Horizon. Frontiers in Pharmacology 12.
Crossref
Crossref
Ricardo Romiti, André Luís da Silva Hirayama, Marcelo Arnone & Renata Ferreira Magalhães. (2022) Generalized pustular psoriasis (von Zumbusch). Anais Brasileiros de Dermatologia 97:1, pages 63-74.
Crossref
Crossref
Min Zheng, Denis Jullien & Kilian Eyerich. (2022) The Prevalence and Disease Characteristics of Generalized Pustular Psoriasis. American Journal of Clinical Dermatology 23:S1, pages 5-12.
Crossref
Crossref
James Krueger, Lluís Puig & Diamant Thaçi. (2022) Treatment Options and Goals for Patients with Generalized Pustular Psoriasis. American Journal of Clinical Dermatology 23:S1, pages 51-64.
Crossref
Crossref
Slaheddine Marrakchi & Lluis Puig. (2022) Pathophysiology of Generalized Pustular Psoriasis. American Journal of Clinical Dermatology 23:S1, pages 13-19.
Crossref
Crossref
Siew Eng Choon, Alexander A. Navarini & Andreas Pinter. (2022) Clinical Course and Characteristics of Generalized Pustular Psoriasis. American Journal of Clinical Dermatology 23:S1, pages 21-29.
Crossref
Crossref
Carmen Maria Salavastru, Ioana Ionescu, Sabina Andrada Zurac & Adelina Maria Șendrea. 2022. Clinical Cases in Middle-Years Pediatric Dermatology. Clinical Cases in Middle-Years Pediatric Dermatology
33
38
.
Alan Menter, Abby S. Van Voorhees & Sylvia Hsu. (2021) Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options. Dermatology and Therapy 11:6, pages 1917-1929.
Crossref
Crossref
Sukhbir Singh, Neelam Sharma, Tapan Behl, Bidhan Chandra Sarkar, Hasi Rani Saha, Kanika Garg, Supriya Kamari Singh, Sandeep Arora, Md. Shah Amran, Ahmed A. H. Abdellatif, Anwar L. Bilgrami, Ghulam Md Ashraf & Md. Sohanur Rahman. (2021) Promising Strategies of Colloidal Drug Delivery-Based Approaches in Psoriasis Management. Pharmaceutics 13:11, pages 1978.
Crossref
Crossref
Ronak Miladi, Alireza Janbakhsh, Arefeh Babazadeh, Zeinab Aryanian, Soheil Ebrahimpour, Mohammad Barary, Terence T. Sio, Uwe Wollina, Mohamad Goldust & Zeinab Mohseni Afshar. (2021) Pustular psoriasis flare‐up in a patient with COVID‐19. Journal of Cosmetic Dermatology 20:11, pages 3364-3368.
Crossref
Crossref
Akimichi Morita, Nirali Kotowsky, Ran Gao, Reiko Shimizu & Yukari Okubo. (2021) Patient characteristics and burden of disease in Japanese patients with generalized pustular psoriasis: Results from the Medical Data Vision claims database. The Journal of Dermatology 48:10, pages 1463-1473.
Crossref
Crossref
Dominik Samotij, Justyna Szczęch & Adam Reich. (2021) Generalized Pustular Psoriasis: Divergence of Innate and Adaptive Immunity. International Journal of Molecular Sciences 22:16, pages 9048.
Crossref
Crossref
Jeffrey Crowley, Amanda K. Golembesky, Nirali Kotowsky, Ran Gao, Rhonda L. Bohn, Elizabeth M. Garry, Julia A. Pisc, Wendell C. Valdecantos, Steven R. Feldman & Alan Menter. (2021) Clinical Characteristics and HealthCare Resource Utilization in Patients With Generalized Pustular Psoriasis: Real-World Evidence From a Large Claims-Based Dataset. Journal of Psoriasis and Psoriatic Arthritis 6:3, pages 151-158.
Crossref
Crossref
Jeffrey M. Sobell, Ran Gao, Amanda K. Golembesky, Nirali Kotowsky, Elizabeth M. Garry, Erin O. Comerford, Rhonda L. Bohn, Wendell C. Valdecantos, Steven R. Feldman & Craig Leonardi. (2021) Healthcare Resource Utilization and Baseline Characteristics of Patients With Generalized Pustular Psoriasis: Real-World Results From a Large US Database of Multiple Commercial Medical Insurers. Journal of Psoriasis and Psoriatic Arthritis 6:3, pages 143-150.
Crossref
Crossref
Julia Borowczyk, Maria Shutova, Nicolo Costantino Brembilla & Wolf-Henning Boehncke. (2021) IL-25 (IL-17E) in epithelial immunology and pathophysiology. Journal of Allergy and Clinical Immunology 148:1, pages 40-52.
Crossref
Crossref
Pablo A. Vieyra-Garcia & Peter Wolf. (2021) A deep dive into UV-based phototherapy: Mechanisms of action and emerging molecular targets in inflammation and cancer. Pharmacology & Therapeutics 222, pages 107784.
Crossref
Crossref
Ping Xia, Yan-Hong Li, Zhong Liu, Xu Zhang, Qian Jiang, Xiao-Yong Zhou & Wei Su. (2021) Recalcitrant paradoxical pustular psoriasis induced by infliximab: Two case reports. World Journal of Clinical Cases 9:15, pages 3655-3661.
Crossref
Crossref
Shantanu Srivatsa, J. Scott Boswell & Thaddeus W. Mully. (2021) Infantile pustular psoriasis: Case report of successful treatment with acitretin in a 4-week-old infant. JAAD Case Reports 11, pages 121-123.
Crossref
Crossref
Helena Iznardo & Lluís Puig. (2021) Exploring the Role of IL-36 Cytokines as a New Target in Psoriatic Disease. International Journal of Molecular Sciences 22:9, pages 4344.
Crossref
Crossref
Bruce Strober, Nirali Kotowsky, Rose Medeiros, Rachel H. Mackey, Leslie R. Harrold, Wendell C. Valdecantos, Mary Flack, Amanda K. Golembesky & Mark Lebwohl. (2021) Unmet Medical Needs in the Treatment and Management of Generalized Pustular Psoriasis Flares: Evidence from a Survey of Corrona Registry Dermatologists. Dermatology and Therapy 11:2, pages 529-541.
Crossref
Crossref
Christian Kromer, Emilia Loewe, Marthe‐Lisa Schaarschmidt, Andreas Pinter, Sascha Gerdes, Raphael Herr, Sietske Poortinga, Rotraut Moessner & Dagmar Wilsmann‐Theis. (2021) Drug survival in the treatment of generalized pustular psoriasis: A retrospective multicenter study. Dermatologic Therapy 34:2.
Crossref
Crossref
Ranjitha Uppala, Lam C. Tsoi, Paul W. Harms, Bo Wang, Allison C. Billi, Emanual Maverakis, J. Michelle Kahlenberg, Nicole L. Ward & Johann E. Gudjonsson. (2020) “Autoinflammatory psoriasis”—genetics and biology of pustular psoriasis. Cellular & Molecular Immunology 18:2, pages 307-317.
Crossref
Crossref
Sarah Reynolds, Simon Matteus, Manikanta Ajay Krishna Kasina, Damian Roland & Christina Rodriguez-Garcia. (2021) When is a rash not ‘just’ a rash? A guide to recognition and treatment of paediatric dermatological emergencies. Paediatrics and Child Health 31:1, pages 46-54.
Crossref
Crossref
Takuya Takeichi & Masashi Akiyama. 2021. New and Emerging Entities in Dermatology and Dermatopathology. New and Emerging Entities in Dermatology and Dermatopathology
3
20
.
Jing Zhang, Chao Ji, Bo Cheng, Shi-Fan Ruan, Tao LiuJin-Wen Huang. (2020) Real-world clinical experience of secukinumab in Chinese patients with psoriasis in real-world practice: a 36-week single-center study of 24 patients. Chinese Medical Journal 133:24, pages 3020-3022.
Crossref
Crossref
Ryokichi Taguchi, Saori Takamura & Yuichi Teraki. (2020) Combination therapy with biologic and colchicine for generalized pustular psoriasis. International Journal of Dermatology 59:11.
Crossref
Crossref
Ruth Neuhauser, Kilian Eyerich & Alexander Boehner. (2020) Generalized pustular psoriasis—Dawn of a new era in targeted immunotherapy. Experimental Dermatology 29:11, pages 1088-1096.
Crossref
Crossref
Yingying Han, Arnaud Huard, Javier Mora, Priscila da Silva, Bernhard Brüne & Andreas Weigert. (2020) IL-36 family cytokines in protective versus destructive inflammation. Cellular Signalling 75, pages 109773.
Crossref
Crossref
Nikolaos Patsinakidis, N. Helge Meyer & Ulrike Raap. (2020) Psoriasis - das kann der Hausarzt tunPsoriasis. MMW - Fortschritte der Medizin 162:S3, pages 43-50.
Crossref
Crossref
Kazuhisa Furue, Dugarmaa Ulzii, Yuka Tanaka, Takamichi Ito, Gaku Tsuji, Makiko Kido‐Nakahara, Takeshi Nakahara & Masutaka Furue. (2020) Pathogenic implication of epidermal scratch injury in psoriasis and atopic dermatitis. The Journal of Dermatology 47:9, pages 979-988.
Crossref
Crossref
Artsiom Klimko, Georgiana A Toma, Laura Ion, Ana Maria Mehedinti & Iuliana Andreiana. (2020) A Case Report of Generalized Pustular Psoriasis Associated With IgA Nephropathy. Cureus.
Crossref
Crossref
Joan Manils, Louise V Webb, Ashleigh Howes, Julia Janzen, Stefan Boeing, Anne M Bowcock & Steven C Ley. (2020) CARD14E138A signalling in keratinocytes induces TNF-dependent skin and systemic inflammation. eLife 9.
Crossref
Crossref
Yi-Wei Huang & Tsen-Fang Tsai. (2020) Pharmacological Management of Pediatric Pustular Psoriasis. Pediatric Drugs 22:3, pages 265-277.
Crossref
Crossref
Katharina Hansel, Rossella Marietti, Marta Tramontana, Leonardo Bianchi, Paolo Romita, Roberta Giuffrida & Luca Stingeni. (2020) Childhood generalized pustular psoriasis: Successful long‐term treatment with adalimumab. Dermatologic Therapy 33:3.
Crossref
Crossref
Kayadri Ratnarajah, Abdulhadi Jfri, Ivan V. Litvinov & Elena Netchiporouk. (2020) Spesolimab: A Novel Treatment for Pustular Psoriasis. Journal of Cutaneous Medicine and Surgery 24:2, pages 199-200.
Crossref
Crossref